FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize
- Mark Ziats
- Mar 16
- 1 min read
Compounded versions of Semaglutide (Ozempic / Wegovy) and Tirzepitide (Monjuro and Zepbound) are no longer legal, with further FDA clarity on the topic published this week, see below:
Source: U.S. Food and Drug Administration
See my recent summary of this topic here:
Comments